(Q33342699)

26 July 2017

title

Raltitrexed in the treatment of elderly patients with advanced colorectal cancer: an active and low toxicity regimen (English)

1 reference

26 July 2017

1 reference

1 reference

C Camps

3

0 references

author name string

J Feliu

1

1 reference

26 July 2017

J R Mel

2

1 reference

26 July 2017

P Escudero

4

1 reference

26 July 2017

J Aparicio

5

1 reference

26 July 2017

D Menéndez

6

1 reference

26 July 2017

C García Girón

7

1 reference

26 July 2017

M R Rodriguez

8

1 reference

26 July 2017

J J Sánchez

9

1 reference

26 July 2017

M González Barón

10

1 reference

26 July 2017

Oncopaz Cooperative Group Associated Hospitals

11

1 reference

26 July 2017

publication date

1 June 2002

1 reference

European Journal of Cancer

26 July 2017

published in

1 reference

26 July 2017

volume

38

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

1204-1211

1 reference

26 July 2017

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Colorectal cancer: detection, treatment, and rehabilitation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Survival of colorectal cancer patients in Europe during the period 1978–1989

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Comorbidity and colorectal cancer according to subsite and stage: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Tomudex International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Management of cancer in the older person: a practical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900005-9

7 January 2021

10.1016/S0959-8049(02)00005-9

Identifiers

DOI

1 reference

26 July 2017

1 reference